loadpatents
name:-0.030887126922607
name:-0.027204990386963
name:-0.030837059020996
LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. Patent Filings

LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD..The latest application filed is for "treatment use of pyrrolopyrimidine compound, and solid pharmaceutical composition of pyrrolopyrimidine compound".

Company Profile
35.45.30
  • LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. - Lianyungang City, Jiangsu Province CN
  • LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. - Lianyungang CN
  • LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. - Lianyungang City, Jiangsu CN
  • LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. - Jiangsu CN
  • LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. - Lianyungang City CN
  • Lianyungang Runzhong Pharmaceutical Co., Ltd. - Lianyungang, Jiangsu CN
  • LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. - Lianyungang, Jiangsu Province N/A CN
  • LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. - Lianyugang City CN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment Use Of Pyrrolopyrimidine Compound, And Solid Pharmaceutical Composition Of Pyrrolopyrimidine Compound
App 20220072002 - WANG; Dong ;   et al.
2022-03-10
Crystalline sulfamide compound
Grant 11,254,665 - Zhang , et al. February 22, 2
2022-02-22
Iridinesulfonamide compound and use method thereof
Grant 11,203,586 - Zhu , et al. December 21, 2
2021-12-21
Sulfoximine Compound As Bromodomain Protein Inhibitor And Pharmaceutical Composition And Medical Use Thereof
App 20210300923 - LI; Jijun ;   et al.
2021-09-30
Solid Pharmaceutical Composition Containing 1,3,5-triazine Derivative Or Salt Thereof
App 20210275534 - SUN; Yuanyuan ;   et al.
2021-09-09
Sultam compound and application method thereof
Grant 11,111,240 - Zhu , et al. September 7, 2
2021-09-07
Macrocycle containing aminopyrazole and pyrimidine and pharmaceutical composition and use thereof
Grant 11,098,060 - Dai , et al. August 24, 2
2021-08-24
1,3,5-triazine Derivative Salt, Crystal, Preparation Method, Pharmaceutical Composition And Use Thereof
App 20210246119 - Huang; Ticong ;   et al.
2021-08-12
Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluorom- ethyl)pyridin-4-yl)-1,3,5-triazin-2-amine methanesulfonic acid salt
Grant 11,021,464 - Huang , et al. June 1, 2
2021-06-01
Iridinesulfonamide Compound And Use Method Thereof
App 20210155610 - ZHU; Li ;   et al.
2021-05-27
Sultam Compound And Application Method Thereof
App 20210047314 - ZHU; Li ;   et al.
2021-02-18
Crystal of salt of quinazoline derivative
Grant 10,858,340 - Tang , et al. December 8, 2
2020-12-08
Crystals Of Aniline Pyrimidine Compound Serving As Egfr Inhibitor
App 20200361908 - ZHU; Yizhong ;   et al.
2020-11-19
Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor
Grant 10,829,492 - Zhu , et al. November 10, 2
2020-11-10
Crystal of DPP-IV long-acting inhibitor and salt
Grant 10,822,319 - Sang , et al. November 3, 2
2020-11-03
Crystalline Sulfamide Compound
App 20200291012 - ZHANG; Xiquan ;   et al.
2020-09-17
Macrocycle Containing Aminopyrazole And Pyrimidine And Pharmaceutical Composition And Use Thereof
App 20200291042 - DAI; Liguang ;   et al.
2020-09-17
Preparation method for chiral pyrrolopyrimidine compound
Grant 10,766,901 - Zhang , et al. Sep
2020-09-08
1,3,5-triazine derivative and method of using same
Grant 10,745,383 - Zhao , et al. A
2020-08-18
1,3,5-triazine derivative and method of using same
Grant 10654826 -
2020-05-19
Pyrrolopyrimidine crystal for preparing JAK inhibitor
Grant 10,626,118 - Zhou , et al.
2020-04-21
Pyrrolopyrimidine comprising cyclopentyl substituent
Grant 10,617,692 - Zhu , et al.
2020-04-14
Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereof
Grant 10,570,141 - Wang , et al. Feb
2020-02-25
Pyrrolopyrimidine compound
Grant 10,561,657 - Zhu , et al. Feb
2020-02-18
1,3,5-triazine Derivative Salt, Crystal, Preparation Method, Pharmaceutical Composition And Use Thereof
App 20190352281 - Huang; Ticong ;   et al.
2019-11-21
Amino Pyrazolopyrimidine Compound Used As Neurotrophic Factor Tyrosine Kinase Receptor Inhibitor
App 20190352306 - ZHU; Li ;   et al.
2019-11-21
Pyrrolopyrimidine Crystal For Preparing Jak Inhibitor
App 20190330215 - Zhou; Zhou ;   et al.
2019-10-31
Substituted Pyrrolopyrimidine Cdk Inhibitor, Pharmaceutical Composition Containing Same And Use Thereof
App 20190300533 - Wang; Shulong ;   et al.
2019-10-03
Crystal Of Dpp-iv Long-acting Inhibitor And Salt
App 20190284153 - Sang; Guangming ;   et al.
2019-09-19
Crystals Of Aniline Pyrimidine Compound Serving As Egfr Inhibitor
App 20190256497 - ZHU; YIZHONG ;   et al.
2019-08-22
Pyridine substituted 2-aminopyridine protein kinase inhibitor crystal
Grant 10,385,038 - Gong , et al. A
2019-08-20
Preparation Method For Chiral Pyrrolopyrimidine Compound
App 20190211021 - ZHANG; Xiquan ;   et al.
2019-07-11
Pyrrolopyrimidine Compound
App 20190201403 - Zhu; Li ;   et al.
2019-07-04
N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-O- XO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acryla- mide hydrochloride as an inhibitor of epidermal growth factor receptor activity
Grant 10,329,277 - Zhu , et al.
2019-06-25
Pyrrolopyrimidine Comprising Cyclopentyl Substituent
App 20190183899 - ZHU; Li ;   et al.
2019-06-20
Crystal Of Salt Of Quinazoline Derivative
App 20190185453 - TANG; Song ;   et al.
2019-06-20
Salts of quinazoline derivative and method for preparing the same
Grant 10,231,973 - Zhang , et al.
2019-03-19
1,3,5-triazine Derivative And Method Of Using Same
App 20190062308 - ZHAO; Na ;   et al.
2019-02-28
Process for preparing ibrutinib
Grant 10,214,532 - Zhang , et al. Feb
2019-02-26
Tricyclic Compound For Bromodomain-containing Protein Inhibitor And Preparation Pharmaceutical Composition, And Application Thereof
App 20190040063 - LI; Jijun ;   et al.
2019-02-07
Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors
Grant 10,155,775 - Xu , et al. Dec
2018-12-18
Antitumor compound targeting IDH2 mutation and method of use thereof
Grant 10,155,722 - Wang , et al. Dec
2018-12-18
Pyridine Substituted 2-aminopyridine Protein Kinase Inhibitor Crystal
App 20180244649 - GONG; Feng ;   et al.
2018-08-30
Antitumor Compound Targeting Idh2 Mutation And Method Of Use Thereof
App 20180222853 - WANG; Shulong ;   et al.
2018-08-09
Aniline Pyrimidine Derivatives And Uses Thereof
App 20180208581 - ZHU; Yan ;   et al.
2018-07-26
Pyridine-substituted 2-aminopyridine protein kinase inhibitors
Grant 9,981,946 - Gong , et al. May 29, 2
2018-05-29
Substituted Amino Six-membered Saturated Heteroalicycles As Long-acting Dpp-iv Inhibitors
App 20180111950 - XU; Xinhe ;   et al.
2018-04-26
Salts Of Quinazoline Derivative And Method For Preparing The Same
App 20180085369 - ZHANG; Xiquan ;   et al.
2018-03-29
Process For Preparing Ibrutinib
App 20180044339 - ZHANG; Xiquan ;   et al.
2018-02-15
Pyridine-substituted 2-aminopyridine Protein Kinase Inhibitors
App 20170226084 - GONG; Feng ;   et al.
2017-08-10
Quinazoline derivative and preparation method therefor
Grant 9,725,439 - Xiao , et al. August 8, 2
2017-08-08
Substituted 2-aminopyridine protein kinase inhibitor
Grant 9,708,295 - Xiao , et al. July 18, 2
2017-07-18
Quinazoline Derivative And Preparation Method Therefor
App 20160214964 - XIAO; Dengming ;   et al.
2016-07-28
Substituted 2-aminopyridine Protein Kinase Inhibitor
App 20160002205 - Xiao; Dengming ;   et al.
2016-01-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed